International: +1-347-960-6455

Research Reports

Filter By Therapeutic Area

Filtered by Therapeutic Areas (Dermatology)

Dermatology
Psoriasis Therapeutics – Pipeline Analysis 2019, Clinical Trials and Results, Patents, Designations, Collaborations, and Other Developments
Report Category Competitive Landscape Reports

Psoriasis is a medical condition that includes chronic inflammation and scaling on skin and develops when skin cells rapidly grow below the surface of the skin and get deposited on the surface before they get mature.

Dermatology
Androgenetic Alopecia Therapeutics – Competitive Landscape, Epidemiology Forecast, and Pipeline Analysis, 2019
Report Category Indication Pipeline Reports

Androgenetic alopecia is a genetic medical condition, which leads to pattern hair loss in both male and female. A pattern of “M” shaped is commonly seen in patients, followed by thinning of hair over the crown.

Dermatology
Hyperhidrosis Therapeutics - Pipeline Analysis 2019, Clinical Trials and Results, Patents, Designations, Collaborations, and Other Developments
Report Category Indication Pipeline Reports

Hyperhidrosis is a condition in which a person starts sweating excessively. People suffering from hyperhidrosis experience excessive sweating from their palms, heads, feet, or underarms.

Dermatology
Interleukin-6 (IL-6) Inhibitors - Pipeline Analysis 2019, Clinical Trials and Results, Patents, Designations, Collaborations, and Other Developments
Report Category Mechanism of Action Reports

IL-6 is transcribed by IL-6 gene that encodes a cytokine, which functions in inflammation and maturation of B cells. The IL-6 protein can induce fever in patients suffering from autoimmune diseases, thereby acting as endogenous pyrogens.

Dermatology
Hypertrophic Scars Therapeutics - Pipeline Analysis 2019, Clinical Trials and Results, Patents, Designations, Collaborations, and Other Developments
Report Category Indication Pipeline Reports

Hypertrophic scar can be identified as a thickened and raised scar that develops at the site where skin is injured. A hypertrophic scar is a result of an abnormal response to a trauma or injury.

Dermatology
Janus Kinase (JAK) Inhibitors - Pipeline Analysis 2019, Clinical Trials and Results, Patents, Designations, Collaborations, and Other Developments
Report Category Mechanism of Action Reports

JAK consists of four intracellular non-receptor tyrosine kinases that help in cytokine mediated signaling through the JAK-STAT pathway. It contains two almost identical phosphate transferring domains in which one domain shows kinase activity and the other regulates the activity of the first via negative inhibition.

Dermatology
Galectin Inhibitor Therapeutics - Pipeline Analysis 2019, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Report Category Mechanism of Action Reports

Galectins belong to the family of animal lectins and perform function by interacting with cytoplasmic and nuclear proteins, cell-surface and extracellular matrix glycoproteins and glycolipids to modulate signalling pathways.

Dermatology
Epidermal Growth Factor Receptor (EGFR) Antagonists Therapeutics - Pipeline Analysis 2019, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Report Category Mechanism of Action Reports

Epidermal growth factor receptors (EGFR) are a group of receptor tyrosine kinase (RTK) that plays a major role in cell proliferation, survival and differentiation. In most of the cancer, EGFR are amplified and overexpressed, due to dysregulation, resulting in cancer development.

Dermatology
Mitogen-Activated Protein Kinase (MAPK) Inhibitors Therapeutics - Pipeline Analysis 2019, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Report Category Mechanism of Action Reports

Mitogen-activated protein kinase (MAPK) are ubiquitous regulators of many cellular functions including cell proliferation, cellular growth, inflammatory responses to stress signals and cell differentiation.

Dermatology
Interleukin Receptor Modulators Therapeutics - Pipeline Analysis 2019, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Report Category Mechanism of Action Reports

Interleukin receptors are a group of cytokine receptors that are expressed by leukocytes. Interleukin receptors play an important role in the functioning of the immune system.

Dermatology
Hepatocyte Growth Factor (HGF) Inhibitor Therapeutics - Pipeline Analysis 2019, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Report Category Mechanism of Action Reports

Hepatocyte growth factor (HGF) is secreted by human pancreatic stellate cells and present predominantly on cancer cells. Thus, HGF inhibitors has emerged as an effective therapy in preventing local tumor growth.

Dermatology
Spleen Tyrosine Kinase (Syk) Inhibitor Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Report Category Mechanism of Action Reports

Spleen tyrosine kinase (Syk) is a protein that belongs to the family of tyrosine kinases with an ability to initiate the inflammatory responses, by connecting immune cell receptors to intracellular signaling pathways.

Dermatology
RNA Interference (RNAi) Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Report Category Mechanism of Action Reports

RNA interference (RNAi) is a molecule type that silences the gene and limits the transcription of the mutated gene. Gene silencing is a novel mechanism that inactivates the transcripts of mutated gene, by activating sequence specific RNA degradation process.

Dermatology
p53 Antigen Modulators Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Report Category Mechanism of Action Reports

p53 is the tumor suppressor transcription factor that activates to various stimulus, including uncontrolled cell proliferation, oncogene over-expression, and DNA damage. p53 antigen modulators helps in preventing cancer development through regulation of cell cycle and apoptosis.

Dermatology
Cytotoxic T-Lymphocyte Antigen-4 (CTLA-4) Inhibitor Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Report Category Mechanism of Action Reports

Cytotoxic T-lymphocyte antigen-4 (CTLA-4) plays important role in the T-cell regulation at an early stage of naive T-cell activation, primarily in the lymph nodes. CTLA-4 has emerged as an attractive cancer immunotherapy as a part of “immune checkpoint blockade”.

Dermatology
Cell Cycle Inhibitors Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Report Category Mechanism of Action Reports

Cell cycle inhibitors include cyclin inhibitors and cyclin-dependent kinases (CDKs), which plays major role in developing new class of anti-cancer therapies. Also, cell cycle inhibitors in combination with chemotherapy, overcome drug resistance and improve cytotoxic efficacy. CDKs are rational targets for cancer treatment, that could restore cell-cycle checkpoints and may induce apoptosis.

Dermatology
Aurora Kinase Inhibitor Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Report Category Mechanism of Action Reports

Aurora kinase are proteins that function as mitotic regulators and are aberrantly expressed in cancerous cells. Aurora kinase inhibitors target these aberrantly expressed regulators, provides genetic stability and prevents tumorigenesis.

Dermatology
Angiopoietin (ANG) Inhibitors Therapeutics - Pipeline Analysis 2019, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Report Category Mechanism of Action Reports

Angiopoietin (ANG) receptor plays a crucial role in regulation of vascular permeability and pathological vascular remodelling during tumour angiogenesis, metastasis and inflammation. Thus, it has emerged as a new clinical approach for the development of therapeutics which treat cancer and ophthalmological diseases.

Dermatology
Androgen Receptor Antagonist Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Report Category Mechanism of Action Reports

Androgens are responsible for the development of male characteristics by binding to androgen receptors. Androgen receptor plays an important role in the development and progression of prostate cancer. Thus, it has been an attractive target for the clinical interventions and treatment of prostate cancer.

Dermatology
Alpha-Synuclein Inhibitor Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Report Category Mechanism of Action Reports

Alpha-synuclein is a protein that is abundantly found in the brain. The minimal amount of alpha-synuclein is also found in the heart and other tissues. The protein is prominently found at the tips of the nerve cells. It helps in the maintaining supply of the synaptic vesicle in presynaptic terminals. In addition, the alpha-synuclein protein also helps in release of dopamine.

Dermatology
Vitiligo Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Report Category Indication Pipeline Reports

Vitiligo is a type of autoimmune disorder which is characterized by white patches on skin. This is mainly due to destruction of melanocytes (cells responsible for pigmentation in the skin). People with certain autoimmune diseases are more prone to developing vitiligo. Some of the most common symptoms of the disease are occurrence of white patches on the hands, feet, arms, and lips.

Dermatology
Venous Leg Ulcers (VLUs) Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Report Category Indication Pipeline Reports

Venous leg ulcers (VLUs) are defined as open lesions between the knee and ankle joint. It is the most common cause of leg ulcers, accounting for 60-80% of the total reported cases. The prevalence of VLUs is between 0.18% and 1%, which increases with age and can increased to 4% in patients aged 65 or above.

Dermatology
Prurigo Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Report Category Indication Pipeline Reports

Prurigo is a group of skin diseases characterised by intensely pruritic, and difficult to treat. There are two conditions associated with prurigo which includes nodular prurigo and papular prurigo. Nodular prurigo is characterized by symmetrical lesions usually on the distal limbs; while, papular prurigo represents smaller lesions which affect cape area.

Dermatology
Keratitis Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Report Category Indication Pipeline Reports

Keratitis is an inflammatory eye disorder which affects cornea. It is mainly caused by virus, bacteria, amoebic, and parasitic pathogens. Red eye, pain, excessive tearing, impaired eyesight, and photophobia are some of the symptoms associated with the disease. Keratitis is categorised into two types: acute keratitis and chronic keratitis.

Dermatology
Keloids Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Report Category Indication Pipeline Reports

A keloid is characterized by abnormal proliferation of scar tissue which occurs at the site of cutaneous injuries. Acne scars, burns, scratches, ear piercing, chickenpox scars, surgical incision sites and vaccination sites are some of the major causes of keloids.

Dermatology
Hidradenitis Suppurativa Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Report Category Indication Pipeline Reports

Hidradenitis suppurativa is a dermatological disorder which develops pimples, folliculitis, boils and deep-acne like cysts and blackheads. The pimples grow deeply in the skin and becomes painful in severe cases. Smoking and obesity are the most common risk factors of hidradenitis suppurativa. It is more prevalent in women compared to men. Hidradenitis suppurativa generally occurs in areas like underarms, groin, buttocks, upper thighs and breasts.

Dermatology
Dermatomyositis Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Report Category Indication Pipeline Reports

Dermatomyositis is a rare inflammatory disease which can occur in any age. However, it is most common in children age group of 5 to 15 years, and people of late 40's and early 60's. Some of the most common symptoms observed in patients with dermatomyositis are erythema, inflammatory myopathy, myalgia, progressive muscle weakness, eyelid abnormality, and periorbital edema.

Dermatology
Dermatomycoses Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Report Category Indication Pipeline Reports

Dermatomycoses is a group of disease which is caused by dermatophytes, a fungus, which generally invade into keratinized tissues such as nails, skin and hairs. The causative agents for dermatomycoses include organisms of three genera, Microsporum, Trichophyton, and Deuteromycetes. Dermatomycoses is a contagious disease that can be acquired from infected animals.

Dermatology
Aging Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Report Category Indication Pipeline Reports

Aging is a process of becoming older, that brings physical, social and psychological changes to the body. In addition, aging is one of the major risk factors for the occurrence of many diseases. The cause of aging is still unknown; however, some proposed theories such as damage accumulation and programmed aging, are heading the hypothetical process of aging.

Dermatology
Actinic Keratosis Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Report Category Indication Pipeline Reports

Actinic keratosis is a type of dermatological disorder characterized by thick and scaly patch of skin, that can lead to cancer. This disease generally occurs at the areas that are exposed to the sun and is common in people with fair skin.